The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice
Authors
Keywords
Triterpenoid, Interleukin-17, Splenocytes, Colitis, Mice
Journal
INFLAMMOPHARMACOLOGY
Volume 22, Issue 6, Pages 341-349
Publisher
Springer Nature
Online
2014-04-09
DOI
10.1007/s10787-014-0203-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tu1617 The Synthetic Triterpenoid (CDDO-IM) Inhibits STAT3, As Well As IL-17, and Improves DSS-Induced Colitis in Mice
- (2015) Elizabeth Stonesifer et al. GASTROENTEROLOGY
- Inhibition of IL-17 as a Pharmacological Approach for IBD
- (2013) Leo R. Fitzpatrick INTERNATIONAL REVIEWS OF IMMUNOLOGY
- A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
- (2012) D. S. Hong et al. CLINICAL CANCER RESEARCH
- Th17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes?
- (2012) I. Monteleone et al. CURRENT MOLECULAR MEDICINE
- Inhibition of Pim-1 Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice
- (2012) Yue-Ming Shen et al. DIGESTIVE DISEASES AND SCIENCES
- IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
- (2012) Annalisa Camporeale Frontiers in Bioscience-Landmark
- IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+Th17 cells
- (2012) Margherita Coccia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis
- (2011) Tej K. Pareek et al. Scientific Reports
- Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
- (2010) K. T. Liby et al. Cancer Prevention Research
- NF-κB and STAT3 – key players in liver inflammation and cancer
- (2010) Guobin He et al. CELL RESEARCH
- 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease†
- (2010) Leo R. Fitzpatrick et al. INFLAMMATORY BOWEL DISEASES
- The Synthetic Triterpenoid, CDDO-Me, Modulates the Proinflammatory Response to In Vivo Lipopolysaccharide Challenge
- (2010) Jeffery J. Auletta et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
- (2009) Caroline E. Sutton et al. IMMUNITY
- Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
- (2009) Melanie A. Kleinschek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice
- (2008) Reiko Ito et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis
- (2008) Leo R. Fitzpatrick et al. BRITISH JOURNAL OF NUTRITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started